文献速递神经肿瘤

立体定向放射外科治疗术后世界卫生组织I级颅底脑膜瘤的长期结局:Ki-67标记指数作为预后指标的效用

Long-Term Outcomes of Stereotactic Radiosurgery for Postoperative World Health Organization Grade I Skull Base Meningioma: Utility of Ki-67 Labeling Index as a Prognostic Indicator.
PubMed 文献 · Neurosurgery · 2023-06-07

这项单中心回顾性研究纳入112例术后接受立体定向放射外科(SRS)的世界卫生组织(WHO)I级颅底脑膜瘤患者,按Ki-67标记指数(LI)分为低(<4%)、中(4%-6%)、高(>6%)三组。结果显示5年和10年累积无进展生存率(PFS)分别为93%和83%,低LI组10年PFS显著高于中、高LI组,多变量分析证实Ki-67 LI与PFS显著相关。作者认为Ki-67 LI可能是术后WHO I级颅底脑膜瘤SRS长期预后的有用预测指标。

要点

  • 112例术后WHO I级颅底脑膜瘤患者接受SRS,5年和10年累积PFS分别为93%和83%。
  • 低Ki-67 LI组10年PFS为95%,显著高于中LI组60%(P=.007)和高LI组20%(P=.001)。
  • 多变量Cox分析显示Ki-67 LI与PFS显著相关:低vs中LI的HR为6.00(95%CI 1.41-25.54,P=.015),低vs高LI的HR为31.90(95%CI 5.59-181.77,P=.001)。

核心结论

  • Ki-67 LI可能是术后WHO I级颅底脑膜瘤SRS长期预后的有用预测指标。
  • SRS在Ki-67 LI<4%或4%-6%的颅底脑膜瘤中提供优异的长期和中期PFS,且放射诱发不良事件风险低。

研究设计与样本

  • 单中心回顾性研究,纳入112例术后接受SRS的WHO I级颅底脑膜瘤患者。
  • 根据Ki-67 LI将患者分为3组:低(<4%)、中(4%-6%)、高(>6%)。
  • 评估影响无进展生存率(PFS)和神经学结局的因素。

主要发现

  • 112例患者的累积5年和10年PFS分别为93%和83%。
  • 低LI组10年PFS为95%,显著高于中LI组60%(P=.007)和高LI组20%(P=.001)。
  • 多变量Cox比例风险分析显示Ki-67 LI与PFS显著相关:低vs中LI的HR为6.00(95%CI 1.41-25.54,P=.015);低vs高LI的HR为31.90(95%CI 5.59-181.77,P=.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gross total resection, without causing neurological deficits, is challenging in skull base meningioma (SBM). Therefore, stereotactic radiosurgery (SRS) is an important approach for SBMs; however, it is difficult to predict the long-term prognosis. OBJECTIVE: To identify the predictive factors for tumor progression after SRS for World Health Organization (WHO) grade I SBMs, focusing on the Ki-67 labeling index (LI). METHODS: In this single-center retrospective study, factors affecting progression-free survival rates (PFSs) and neurological outcomes in patients undergoing SRS for postoperative SBMs were evaluated. Based on the Ki-67 LI, patients were classified into 3 groups: low (<4%), intermediate (4%-6%), and high LI (>6%). RESULTS: In the 112 patients enrolled, the cumulative 5- and 10-year PFSs were 93% and 83%, respectively. The PFSs were significantly higher in the low LI group (95% at 10 years) compared with the other groups (intermediate LI, 60% at 10 years, P = .007; high LI, 20% at 10 years, P = .001). Multivariable Cox proportional hazard analysis demonstrated that the Ki-67 LI was significantly associated with the PFSs (low vs intermediate LI; hazard ratio, 6.00; 95% CI, 1.41-25.54; P = .015; low vs high LI; hazard ratio, 31.90; 95% CI, 5.59-181.77; P = .001). CONCLUSION: Ki-67 LI may be a useful predictor of long-term prognosis in SRS for postoperative WHO grade I SBM. SRS provides excellent long- and mid-term PFSs in SBMs with Ki-67 LIs <4% or 4% to 6%, with a low risk of radiation-induced adverse events.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Shinya Y, Hasegawa H, Shin M, et al. Long-Term Outcomes of Stereotactic Radiosurgery for Postoperative World Health Organization Grade I Skull Base Meningioma: Utility of Ki-67 Labeling Index as a Prognostic Indicator. Neurosurgery. 2023. PMID: 37283526. doi:10.1227/neu.0000000000002546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。